Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_assertion type Assertion NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_head.
- NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_assertion description "[P-cadherin, Vimentin and CK14 can recognize BLBC already identified in triple negative/ CK5 and/or EGFR+ tumors, and due to P-cadherin sensitivity for BLBC identification this marker can reliably recruit a large number of breast carcinomas with basal phenotype among immunohistochemistry triple negative/ CK5 and/or EGFR - pool of tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_provenance.
- NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_assertion evidence source_evidence_literature NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_provenance.
- NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_assertion SIO_000772 20552547 NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_provenance.
- NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_assertion wasDerivedFrom befree-20140225 NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_provenance.
- NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_assertion wasGeneratedBy ECO_0000203 NP480910.RAzVoePtN2uxdvOR1VcmwKL5Uz4QgXrYQ5YLu7wJG95Uk130_provenance.